News from cannabis science, inc A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Sep 29, 2014, 13:56 ET
Sep 16, 2014, 09:05 ET

Cannabis Science, Inc. (CBIS) And Unistraw Holdings Join Forces To Produce Proprietary Formulations Delivering A Wide Array Of Unique Cannabis Extracts And Pure Cannabinoid-Based Products

Cannabis Science, Inc. (OTC: CBIS), a U.S. Company specializing in cannabis formulation-based drug development and related consulting, is pleased...

Aug 25, 2014, 11:17 ET

Cannabis Science, Inc. (CBIS) In Final Negotiations To Acquire British Columbia Company That Has Submitted 'Marihuana For Medical Purposes' License Application To Health Canada

 Cannabis Science, Inc. (OTC-QB: CBIS), a U.S. company specializing in cannabis formulation-based drug development and related consulting, is...

Aug 22, 2014, 08:51 ET

Cannabis Science, Inc. (CBIS) to Sponsor 3rd International Conference on Cannabinoids in Medicine in October 2014 in Strasbourg, France

 Cannabis Science, Inc. (OTC: CBIS), a U.S. Company specializing in cannabis formulation-based drug development and related consulting, is...

Aug 11, 2014, 11:16 ET

Cannabis Science, Inc. (CBIS) Increases Equity Position to 50.1% in Michigan Green Technologies LLC, Positioning Company as Leader in Evolving Michigan Medical Cannabis and Hemp Industries

Cannabis Science, Inc. (OTC-QB: CBIS), a U.S. Company specializing in cannabis formulation-based drug development and related consulting, signs...

Aug 07, 2014, 11:55 ET

Cannabis Science In Final Negotiations To Establish Its First Medical Cannabis Facilities In Canada

 Cannabis Science, Inc. (OTC-QB:CBIS), a U.S. company specializing in cannabis formulation-based drug development and related consulting, is in...

Aug 05, 2014, 11:23 ET

Cannabis Science, Inc. (CBIS) Encouraged by Florida Medical Cannabis Voter Support of 88 Percent; Florida Referendum in November Seen as Key Tipping Point

Cannabis Science, Inc. (OTC-QB: CBIS), a U.S. Company specializing in cannabis formulation-based drug development and related consulting, is...

Aug 05, 2014, 09:06 ET
Aug 05, 2014, 05:45 ET

Cannabis Science pone en marcha estudios preclínicos sobre formulaciones cannabinoides en enfermedades neurológicas

- Cannabis Science pone en marcha estudios preclínicos sobre formulaciones cannabinoides en enfermedades neurológicas, incluyendo...

Aug 04, 2014, 08:40 ET

Cannabis Science Initiates Pre-Clinical Studies on Cannabinoid Formulations in Neurological Diseases Including Sleep Disorders with the Highly Reputable Institute for Health and Science on Ageing - INRCA - in Italy

 Cannabis Science, Inc. (OTCQB: CBIS), a U.S. Company specializing in cannabis formulation-based drug development and related consulting is...

Jul 31, 2014, 11:07 ET
Jul 30, 2014, 07:30 ET

CBIS Very Excited Over Federal Cannabis Legalization Efforts in U.S. House and Senate to Change Medical Cannabis Laws

Cannabis Science, Inc. (OTC: CBIS), a U.S. Company specializing in cannabis formulation-based drug development and related consulting, is extremely...

Jul 29, 2014, 09:20 ET

Cannabis Science, Inc. (CBIS) Applauds New York Times Editorial Board Stance on 'Repealing Prohibition, Again'; NYT Editorial Is Bell Weather of Change

 Cannabis Science, Inc. (OTC: CBIS), a U.S. Company specializing in cannabis formulation-based drug development and related consulting,...

Jul 24, 2014, 07:56 ET

Cannabis Science Appoints Dr. Roscoe M. Moore Jr., US Assistant Surgeon General (retired) for a Second Term on the Scientific Advisory Board as Special Senior Advisor to the Company

Cannabis Science, Inc. (OTCQB: CBIS), a U.S. Company specializing in cannabis formulation-based drug development and related consulting is pleased...

Jul 18, 2014, 13:40 ET
Jul 08, 2014, 09:41 ET

Cannabis Science, Inc. (CBIS) Prepares for New York State as it becomes the 23rd state to authorize Medical Marijuana use

 Cannabis Science, Inc. (OTC: CBIS), a U.S. Company specializing in cannabis formulation-based drug development and related consulting applauds...

Jun 05, 2014, 10:44 ET

Cannabis Science, Inc. (CBIS) Reports Strongest Financial Position in its History, Citing Filings & Financial Statements as the Company Moves Forward with Multiple Cannabis Drug Development Programs

Cannabis Science, Inc. (OTC: CBIS), a U.S. Company specializing in cannabis formulation-based drug development and related consulting, issued...

Jun 03, 2014, 12:22 ET

CBIS Reports on CBS News; Historic Marijuana Vote from United States House of Representatives Creates Serious Confidence as Marijuana Wins U.S. House Vote for First Time in History

Cannabis Science, Inc. (OTC: CBIS), a U.S. Company specializing in cannabis formulation-based drug development is pleased to announce a historic...